Suppr超能文献

0.5%托吡卡胺与0.5%去氧肾上腺素混合滴眼液的睫状肌麻痹作用:对日本近视学龄儿童的客观评估

Cycloplegic effect of 0.5% tropicamide and 0.5% phenylephrine mixed eye drops: objective assessment in Japanese schoolchildren with myopia.

作者信息

Hamasaki Ichiro, Hasebe Satoshi, Kimura Shuhei, Miyata Manabu, Ohtsuki Hiroshi

机构信息

Department of Ophthalmology, Okayama University, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

出版信息

Jpn J Ophthalmol. 2007 Mar-Apr;51(2):111-5. doi: 10.1007/s10384-006-0400-7. Epub 2007 Apr 6.

Abstract

PURPOSE

To evaluate the cycloplegic effect of mixed eye drops containing 0.5% tropicamide and 0.5% phenylephrine in myopic children, and to determine whether their efficacy was associated with their clinical characteristics.

METHODS

Eighty-one myopic children (age, mean +/- SD, 11.0 +/- 1.5 years; mean spherical equivalent refractive error, -4.27 +/- 1.41 D; range, -1.57 to -8.66 D) were recruited. One drop of Mydrin-P was administered to each eye twice, with an interval of 5 min between. Twenty-five minutes after the second drop, accommodative responses were measured with an open-view autorefractometer, while the subject was encouraged to accommodate by binocularly looking at a Maltese cross located at a distance of 33 cm. The difference between the refractive reading and that obtained with a Maltese cross at 500 cm was regarded as residual accommodation (RA). The repeatability of this measurement was also evaluated.

RESULTS

The mean RA was 0.21 +/- 0.29 D (range, -0.31 to 0.99 D). There was no association in RA between the right and left eyes, between RA and age, or between RA and sex, but RA was weakly correlated with refractive error (r = 0.274, P = 0.019). The intersubject difference found in RA can be explained mostly by the extent of repeatability (+/-0.71 D).

CONCLUSION

The insignificant magnitude of RA indicated that the mixed eye drop is an acceptable and useful cycloplegic agent in Japanese schoolchildren with a wide range of myopic refractive errors.

摘要

目的

评估含有0.5%托吡卡胺和0.5%去氧肾上腺素的复方滴眼液对近视儿童的睫状肌麻痹作用,并确定其疗效是否与其临床特征相关。

方法

招募了81名近视儿童(年龄,平均±标准差,11.0±1.5岁;平均等效球镜屈光不正,-4.27±1.41 D;范围,-1.57至-8.66 D)。每只眼睛滴入一滴美多丽-P,间隔5分钟,共滴两次。第二次滴眼25分钟后,使用开放式自动验光仪测量调节反应,同时鼓励受试者通过双眼注视位于33 cm处的马耳他十字来进行调节。屈光读数与在500 cm处用马耳他十字测得的读数之间的差异被视为残余调节(RA)。还评估了该测量的重复性。

结果

平均RA为0.21±0.29 D(范围,-0.31至0.99 D)。右眼和左眼之间、RA与年龄之间或RA与性别之间在RA方面均无关联,但RA与屈光不正呈弱相关(r = 0.274,P = 0.019)。在RA中发现的受试者间差异主要可以由重复性程度(±0.71 D)来解释。

结论

RA的微小程度表明,该复方滴眼液对于日本患有广泛近视屈光不正的学龄儿童是一种可接受且有用的睫状肌麻痹剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验